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The review highlights the clinical presentation of functional movement disorders (FMDs) and presents
current evidence on bedside signs and paraclinical tests to differentiate them from other neurological
disorders.
Recent findings
FMDs are diagnosed by the presence of positive clinical signs as emphasized in the new Diagnostic and
Statistical Manual of Mental Disorders-5 classification criteria. Bedside signs are numerous, and a subset of
them has been validated in controlled studies. This review summarizes evidence from the literature on
specificity and sensibility of positive clinical signs for FMDs. The value of rule-in paraclinical tests to confirm
the diagnosis is also presented. Recent developments in neuroscience with pathophysiological mechanisms
and current treatment strategies are also discussed.
Summary
FMDs represent a field of neurology that is currently rapidly growing in terms of research. Clinicians should
be aware that highly reliable signs exist for the diagnosis and that early multidisciplinary treatment should
be offered.
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Bern, SwitzerlandFunctional movement disorders (FMDs) are defined
as abnormal involuntary movements that are incon-
gruent with a known neurologic cause and neuro-
anatomy. Already known in ancient Greece, they
were considered as a formofhysteria,with symptoms
due to a wandering uterus. The subsequent term
‘conversion’ expressed Sigmund Freud’s theory that
unconscious intrapsychic conflicts were converted
into neurologic physical symptoms. In line with this
view of a causal psychological factor, the term ‘psy-
chogenic’ has then been widely used. New nomen-
clature uses the term ‘functional disorder’ [1], which
is less stigmatizing and offensive [2] and by con-
sequence better accepted by patients. As negative
signs of neurologic disease do not exclude an organic
cause, diagnosis should rely on the presence of
positive clinical characteristics as emphasized in
the newDMS-5 criteria. This reviewwill focus on this
diagnostic aspect by presenting current evidence on
positive clinical signs for FMDs. Physiopathological
mechanisms and current treatment strategies will
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The previous version of the Diagnostic and Statisti-
cal Manual of Mental Disorders (DSM)-IV definedht © 2017 Wolters Kluwe
rs Kluwer Health, Inc. All rights resetional, medically unexplained, neurological symp-
tom (criterion A) with a psychological stressor
(criterion B).
The newDSM-5 version, published inMay 2013,
insists on the importance to make a ‘positive’ diag-
nosis of conversion disorder and to put less weight
on the associated psychological factors. A new
criterion (B) requires that ‘clinical findings provide
evidence for incompatibility between the symptom
and recognized neurological or medical conditions’
[3,4] (American Psychiatric Association, 2013). The
way to provide the evidence for incompatibility is to
use bedside tests [5] or paraclinical tests [6] that are
specific and reliable for functional neurological dis-
order (FND) [7,8]. Earlier diagnostic criteria for func-
tional/psychogenic movement disorders, such as
the original [9] andmodified [10] Fahn andWilliams
criteria, also emphasized incongruence and incom-
patibility with a known neurological condition. Ther Health, Inc. All rights reserved.
rved. www.co-neurology.com
KEY POINTS
 FMDs are defined as abnormal involuntary movements
that are incongruent with a known neurologic cause
and neuroanatomy.
 Diagnosis should rely on the presence of positive
clinical characteristics.
 Psychopathology is not always evident but
psychological factors are important risk factors and/or
maintaining factors.
 Functional movement disorders must be distinguished
from simulating.
 Cerebral dysfunction can be objectified by fMRI.
 Therapeutic approach should be multidisciplinary,
involving both physical therapy and psychiatric care.
Movement disordersadvantage of the new DSM-5 classification is that it
covers not only movement disorder presentation
but also represents a generic classification with sub-
types according to the symptom [e.g. F44.4 for
motor FND (weakness or abnormal movement),
F44.5 for attacks or seizure].CLINICAL EVALUATION
Anamnesis revealing mismatch between impair-
ment and disability, and also history of marked
variability of symptoms or exacerbations with sus-
tained spontaneous remissions can suggest a func-
tional origin. Anamnesis also provides a good
opportunity to start the examination by observing
the symptom’s variations and distractibility during
spontaneous speech and behavior, as it is a typical
functional sign [11].Dystonia
Functional dystonia makes up to nearly a third of all
functional phenotypes [12]. Fluctuations in severity
and variation in tone with passive manipulation, as
observed in other functional disorders as reliable
positive signs, are not very helpful in differentiating
dystonia, as they are often also present in organic
dystonia [13]. Inconsistency in topographic localiz-
ation and severity over time are more useful [12].
Sudden onset and a fixed posture at rest, which
offers marked resistance to passive manipulation,
fixed postures at onset, prompt resolution immedi-
ately after botulinum toxin injections, and variable
generalization to the rest of the body with intermit-
tent episodes of exacerbation are typical features of
functional dystonia [14,15] (Table 1). Copyright © 2017 Wolters Kluwer 
428 www.co-neurology.comTorticollis
Classical phenotype is the painful torticollis with
suddenonsetoftenafter trivial trauma[16,17].Often,
predominant laterocollis with ipsilateral shoulder
elevation and contralateral shoulder depression is
seen. Contralateral shoulder depression and resist-
ance to passive manipulation are only seen in func-
tional cervical dystonia and therefore a good sign to
distinguishing from its organic counterpart.
Foot dystonia
In adults, foot dystonia at rest (nonexercise-
induced, nonparoxysmal) is most often functional,
commonly with a plantar flexion an inversion of the
foot [17]. An unusual variant is the functional ‘stria-
tal toe’ with a fixed first-toe extension and second to
fifth-toe flexion. Extension of first toe is typically
resistant to forced flexion but undergoes spon-
taneous flexion when the examiner extends the
second to fifth toes [18].
Hand dystonia
Functional dystonia of the hand typically involves
the second to fifth fingers with relative or complete
sparing of the thumb, and, in some instances, the
index finger, thus preserving the important pincer
function of the hand [17].Facial movement disorders
Functional facial movement disorders involve the
lips (60.7%), eyelids (50.8%), perinasal region
(16.4%), and forehead (9.8%) [19], resembling ble-
pharospasm, hemifacial spasm, or oromandibular
dystonia [20
&&
].
Typical sign for functional blepharospasm is the
contraction of corrugator (forehead frown) and pro-
cerus muscles (wrinkles the skin overlying the nasal
radix) in the absence of spasm of the orbicularis
oculi, resulting in narrowing of the eyelid fissure,
depression of the eyebrows, but without spasm of
orbicularis oculi [21].
The so-called Babinski ‘other’ sign only seen in
organic blepharospasm (100% specificity) [22,23] is
characterized by an elevation of frontalis on the
same side as orbicularis oculi involvement (narrow-
ing of eyelid fissure and ipsilateral rising of the
eyebrows during eyelid spasms). On the contrary,
functional patients with asymmetric spasm of orbi-
cularis oculi will display rising of eyebrow contrala-
teral to the closing eye [19].
Inability to open the eyes, resembling ‘eyelid-
opening apraxia,’ can be seen [24] and is character-
ized in FND by variable resistance to passive opening
of eyelids (Table 1).Health, Inc. All rights reserved.
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Table 1. Clinical features of functional movement disorders (FMDs)
Features suggesting FMD
Features suggesting organic
disorder
Complementary
examinations
Dystonia Inconsistency in localization and severity over
time
Geste antagoniste
Sudden onset Progressive onset
Fixed posture at rest
Fixed postures at onset
Prompt resolution after botox/suggestion
Torticollis Predominant laterocollis with ipsilateral shoulder
elevation and contralateral shoulder
depression
Prompt resolution after botox
Foot dystonia Nonexercise-induced
Nonparoxysmal
Hand dystonia Spared pincer function (dystonia Dig. II–IV) Involvement Dig I–II
Facial movement
disorders
Eyebrow rising contralateral to closed eye Babinskis ‘other’ sign: narrowing of
eyelid fissure and ipsilateral frowning/
elevation of the eyebrows during
eyelid spasms
Lip-pulling sign Tongue deviation ipsilateral to facial
weakness
Resistance to passive lid opening Persistence during sleep
Tongue deviation contralateral to facial
weakness
Absence during sleep
Tic Adult onset, absence of tics in childhood Perceived as intentional movement
(release inner tension)
Lack of premonitory sensations, Premonitory sensation
Inability to suppress movements
Perceived as involuntary
Tremor Distractibility Constant frequency-peak ENMG
Variability (amplitude/frequency, localization,
direction)
Rhythmic, nondistractible
Entrainment Cave: irregular dystonic tremor
Whack a mole sign
Parkinsonism Bradykinesia without decrement in amplitude Cogwheel, increasing with distraction DAT scan
Resistance without cogwheel, decreasing with
distraction maneuvers
Bradykinesia with decrement in
amplitude
Tremor variable, diminishing during walking Re-emergent tremor
Tremor increasing during walking
Myoclonus Axial myoclonus Short lasting ENMG: inconsistent
pattern, >700 ms
Too slow/complex for organic myoclonus EEG: Bereitschaftspotential
(Backaveraging)
Spinal myoclonus with coexistence of facial
movements/vocalizations
Distractibility, entrainment
Gait Uneconomic postures: knee buckling, astasia-
abasia, ‘tightrope walking’, ‘walking on ice’
Enhancement with distraction
Exaggerated compensatory maneuvers
Huffing and puffing
Improvement with distraction
DAT, Dopamine transporter scan; EEG, Electroencephalogram; ENMG, Electroneuromyography.
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Movement disordersThe most common pattern of facial FMDs con-
sists of tonic, lateral, and/or downward protrusion
of one side of the lower lip with ipsilateral jaw
deviation (84.3%), called ‘lip-pulling sign’ [19].
The tongue may be involved, with ‘wrong-way’
tongue deviation (contralateral to the facial weak-
ness) [25].
Palatal tremor can also be seen in FND, with the
key features of entrainment and distractibility
[26,27].
Functional facial spasms typically disappear
during sleep [19,28] when it can persist in up to
80% of patients with hemifacial spasm [29].Tremor
Functional tremor is the most frequent presentation
of FMD [30]. The tapping task for distraction is the
most reliable positive sign for detection of func-
tional tremor (sensitivity and specificity both
73%) [31]. With distraction (during anamnesis,
mental calculation, examination of other body
part), functional tremor typically dramatically
improves, or changes in frequency and/or ampli-
tude (sensitivity of 58% and specificity of 84%) [31].
By performing a finger-tapping task at a given fre-
quency with the contralateral hand or another body
part, tremor may demonstrate entrainment (tremor
overtakes the frequency of the contralateral move-
ments), another clinical hallmark of functional
tremor [32]. Whereas organic tremors can also have
variable amplitude influenced by the level of
anxiety/exercise/position, variability in frequency
and direction (changing from pronation/supination
to flexion/extension) is typical for functional
tremor. When restricting a tremulous limb, the
tremor may suddenly spread to another limb, so
called ‘whack-a-mole’ sign. [33]. In case of a tremor
irregular in rhythm and direction, differential diag-
nosis of a dystonic tremor should be considered [32].Parkinsonism
Tremor in functional parkinsonism often affects the
dominant hand and is mostly equally present
during rest, posture, and action, opposed to the rest
tremor in Parkinson’s disease, which classically
decreases with action. Further difference is the
absence of a brief pause in tremor when assuming
an outstretched posture of the hands, so-called
re-emergent tremor classically seen in PD [34].
The tremor is distractible and diminishing while
walking, in contrasts with the rest tremor in PD,
which classically enhances when walking. Repeti-
tive movements may be slow, but true bradykinesia
with decrement in amplitude or arrests in Copyright © 2017 Wolters Kluwer 
430 www.co-neurology.commovements is not seen [35]. When assessing tone,
there is active resistance without cogwheeling,
decreasing with distraction maneuvers – the oppo-
site of what occurs in PD [36].Myoclonus
After functional tremor and dystonia, functional
myoclonus and jerks represent the third most com-
mon diagnosis of FMDs [37]. Axial jerks are more
likely to represent functional jerks (58% of proprio-
spinal myoclonus) [38,39]. Arguments in favor of
functional propriospinal myoclonus are [1] previous
somatizations, [2] coexistence of facial involvement
(do not occur with a spinal origin), [3] normal
imaging of the spinal axis [4], and presence of
Bereitschaftspotential (cave: latter can be absent
or not recordable) or inconsistent electromyogram
pattern [39–41]. Functional jerks are distractible,
may show entrainment [3], and are often too slow
or too complex to be organic myoclonus. When
there is stimulus sensitivity, delay is long and var-
iable from the stimulus.Gait
Abnormal gait is a common feature in patients, with
5.7% of FMDs presenting isolated gait disorders and
36.6%mixedmovement disorder with gait disorders
[42]. In pure functional gait, ‘knee-buckling’ is the
most common pattern, followed by astasia-abasia
[43]. Functional impairment of equilibrium is
often accompanied with exaggerated compensatory
maneuvers such as putting the arms out (‘tightrope
walking’), or marked reduction in the step height
and stride length (‘walking on ice’) [44]. These fol-
lowing signs have a high specificity (between 94 and
100%): momentary fluctuations of stance and gait,
excessive slowness or hesitation, psychogenic Rom-
berg test, uneconomic postures, ‘walking on ice,’
and sudden buckling of the knees [8,45]. ‘Huffing
and puffing’ signs (huffing, grimacing, and breath
holding while walking) were present in 44% of
patients with functional gait disorders, but minimal
or absent in organic gait disorder, yielding 89–100%
specificity [46]. Sway may improve in functional
disorders rather than worsen with mental distrac-
tion [47]. Other inconsistency is when patients
complain of poor balance or falls, with preserved
or even skillful balance control to maintain uneco-
nomic postures [45,48] or continuous exaggerated
truncal sway (astasia-abasia) (Table 1).Tic
Functional tics are a rather rare, particularly challeng-
ing because typical features of FMDs (distractibility,Health, Inc. All rights reserved.
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Functional movement disorders Barbey and Aybeksuggestibility) are also characteristic of organic tics
[49,50]. Hints for their diagnosis are: adult onset, no
premonitory sensations, no tics in childhood, nega-
tive family history, inability to suppress movements
(patients with tics can usually suppress their tics for
short periods), and coexistence with other FNDs
[49,51]. Tics are usually experienced as intentional
movements performed in order to relieve inner ten-
sion, whereas functional tics are perceived as invol-
untary [51,52]. Premonitory sensation is considered a
hallmark feature of organic tics, and it is reported in
about 90% of patient (although also reported in
patients with presumed functional tics) [39,52], but
larger studies are needed [49,51] to have definite
views on this issue. (Table 1)COMPLEMENTARY EXAMINATIONS
Electroneuromyography
Electroneuromyography is especially helpful for
tremor analysis and discrimination of different
types of myoclonus or dystonia.
Tremor recording by electromyography (EMG)
and accelerometer (recording the movement,
tremor frequency and amplitude) has a good sensi-
tivity (89.5%) and specificity (95.9%), and also inter-
rater reliability for differential diagnosis of func-
tional versus organic tremor [53
&&
]. Test battery
consisted of the following: tremor recording at rest,
posture (with and without loading), action, while
performing tapping tasks (1, 3, and 5Hz), and while
performing ballistic movements with the less-
affected hand). Tonic muscular co-activation, inter-
manual coherence of tremor frequency, response to
contralateral ballistic movement (pause of tremor),
loading (increased tremor frequency), and correct
tapping performance to a given frequency were
regarded as positive functional signs.
Assessment of jerks is made by surface EMG,
conventional electroencephalogram (EEG), Jerk-
Locked-Back-Averaging (JLBA), somato-sensory
evoked potentials (SEP), and C-reflex studies [54].
The duration of EMG bursts is below 75ms in
organic and above 75ms in psychogenic myoclo-
nus. EEG helps in identifying the cortical origin of a
myoclonic jerks and its temporal relationship with
the cortical activity [54]. Presence of Bereitschaft-
spotenzial [negative cortical potential, maximal
amplitude over the central areas (Cz), starting
2000–1000ms prior to the jerk, associated with
self-initiated movement] in EEG strongly suggests
functional myoclonus [40,41]. Inconsistent muscu-
lar recruitment pattern in EMG with entrainment,
distractibility, and stimulus sensitivity can be
found [55]. Copyright © 2017 Wolters Kluwe
1350-7540 Copyright  2017 Wolters Kluwer Health, Inc. All rights reseIn functional blepharospasm, the blink reflex
(paired supraorbital nerve stimuli) exhibits a normal
recovery cycle (R2) [56], unlike organic blepharo-
spasm (abnormal R2).
In fixed-foot dystonia, an abnormal pattern of
co-contraction of antagonist muscles preceding the
movement can only be observed in functional foot
dystonia [57].Ultrasound
The use of ultrasound can be recommended [58] as a
noninvasive, convenient diagnostic tool for further
studies of diaphragmatic myoclonus. Ultrasound
can evidence distractibility and entrainment of
functional diaphragmatic myoclonus on real-time
video [58].Dopamine transporter scan
Dopamine transporter single-photon emission com-
puted tomography (DAT-SPECT) can be useful in
distinction between functional parkinsonism and
Parkinson’s disease. Normal DAT-SPECT does not
distinguish functional tics from benign tremor dis-
orders (essential or dystonic tremor) or from non-
degenerative parkinsonian disorders (drug-induced
or vascular parkinsonism) [59].PHYSIOPATHOLOGY
With the new DSM-5 classification, diagnosis of
FMD can be made without an identified psychologi-
cal triggering factor [60,61]. Whereas a recent study
confirmed higher rates of childhood trauma in FMD
patients compared to healthy volunteers [62], psy-
chopathology is not always evident; a substantial
proportion of patients (from 0 to 86%) do not report
having experienced traumatic events in their history
[63]. If psychological factors alone are not sufficient
to explain the etiology of FMD, they are still import-
ant risk factors and/or maintaining factors [60,61].
Evidence suggesting abnormal emotional regu-
lation in FND was gathered with increased amygda-
lar [64] and periaqueductal gray (PAG) activity [64]
in patients during negative emotion stimuli. Lack of
habituation in amygdalar activity over time suggests
a general hyperarousal state in FND. Patients may be
more prone than healthy controls to automatic
motor defense behavior, such as freeze response,
mediated by PAG abnormal activity, because this
region is known to be implicated in the freeze
response in both animal [65] and human [66,67
&&
]
studies.
There is also evidence of alteration in autonomic
nerve system function in FMD: decreased vagally
mediated heart rate variability was observed in FMDr Health, Inc. All rights reserved.
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Movement disorderspatients, both [68
&
] adults and children [69], result-
ing in potentially inadequate protection from sym-
pathetic stressors in these patients [68
&
].
Abnormal limbic–motor interaction is sus-
pected to play a role in the generation of motor
symptoms; an fMRI study looking at implicit
emotion processing [64] found a greater connec-
tivity in FMD patients between the amygdala and
the supplementary motor area (SMA), whereas
another found this same hyperconnectivity during
the recall of autobiographical traumatic events [70].
Additional finding from this study was increased
dorsolateral prefrontal cortex activity and concom-
itant reduced hippocampal activity in patients
during recall of the trauma, which is a pattern
involved in active forgetting of unwantedmemories
[70,71], congruent with Freud’s repression theory.
Distinctive changes in brain activation were
found when comparing functional symptoms to
fake symptoms (voluntarily produced by simu-
lators/feigners) [72–76]. Compared to healthy con-
trols and actors feigning weakness, conversion
patients showed decreased dorsolateral prefrontal
cortical activity, and also reduced activation of
the contralateral parietal region and increased per-
fusion in the frontal region. The authors hypothes-
ized that frontal regions were inhibiting the motor
and premotor areas when the patient tried to move
their affected limb, as if the ‘center of volition’ was
malfunctioning. This fitted with a view developed
long ago by James Paget: the patient says ‘I cannot,’
it looks like ‘I will not,’ but it is ‘I cannot will’ [77]. It
is important to note that symptoms are perceived as
involuntary by the patient and by consequence
FMDs must be distinguished from simulating.
Comparing patients when they had their invol-
untary functional tics to a period where they had a
voluntary tremor (order to reproduce their tremor
intentionally), fMRI demonstrated a reduced brain
activity in the right temporo-parietal junction (TPJ),
a key area involved in integrating complex sensory
signals [78,79]. The right TPJ plays an important role
in the sense of agency, which is the sense that we are
the actors of our own actions. The TPJ acts as a
comparator between the feed-forward (intended
movement) and the feedback processes (feedback
of the effectuated movement); when feed-forward
and feedback processesmatch, the sense of agency is
reached. The reduced TPJ activity in functional
patients suggests that patients are no longer able
to perceive their movement as voluntary.TREATMENT AND OUTCOME
Treatment begins with communication of the diag-
nosis to the patient. Use of the term ‘functional Copyright © 2017 Wolters Kluwer 
432 www.co-neurology.comdisorder’ is recommended, as it is descriptive (dis-
order of function of nervous system, no underlying
structural abnormality) and nonjudgmental [2,80].
It should be emphasized that symptoms are real, are
not imagined or simulated, and are potentially
reversible [81
&&
]. The pathological role of attention
toward movement should be explained and distrac-
tion techniques (e.g. music, talking, or altered gait
patterns) can be taught [82
&&
] with the aim to
reinstate automatic neurologic control and redirect
unhelpful movement-focused attention [83]. Fur-
ther medical information on the disorder can be
provided by indicating a website (www.neurosymp-
toms.org) by a neurologist and translated in many
languages and self-help guides [84] can be provided.
The therapeutic approach should be multidisci-
plinary [85] involving the general practitioner,
the neurologist, the physiotherapist, and when
relevant, the psychiatrist, speech therapist, occu-
pational therapist, and social worker.
Physiotherapy has a key role in allowing patients
to better understand the illness and its potentially
reversibility (demonstration that normal movement
can occur), and to retrain movement with diverted
attention [82
&&
]. TENS (transcutaneous electrical
nerve stimulation, producing a tingling sensation)
has been tested as a potential treatment for patients
with functional sensory loss to improve sensory
awareness [82
&&
,86]. Physiotherapy showed improve-
ment of symptoms in 55% of patients at 3 months of
follow-up [87]. Another randomized controlled study
of physical rehabilitation in FMD reported symptom
improvement in 72%of the intervention group (only
18% of the control group) [88
&
].
Accompanying symptoms are frequent (pain,
fatigue, difficulties in concentration) and should
be explained to the patient [82
&&
].
Patients with FNDs often have more than one
symptom and or may develop other functional dis-
orders later during follow-up. [89]. Receiving health-
related benefits has a negative effect on outcome
[90]. Longer duration of symptoms seems to corre-
late with negative outcome [91]. Early diagnosis is
important to prevent chronification. Psychiatric
comorbidity was found to be an inconsistent
predictor of poor outcome [92]. Data concerning
outcome are variable. The largest prospective fol-
low-up study in mixed FNDs (cohort study of 716
patients followed up over a 1-year in Scotland) [90],
outcome was poor with 67% of the patients having
unchanged symptoms or worse.
Psychiatric evaluation is important, as many
FMD patients also suffer from psychiatric co-
morbidities such as anxiety and/or depression, but
often only accepted with a good alliance with the
patient [93].Health, Inc. All rights reserved.
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Functional movement disorders Barbey and AybekA few studies evaluated transcranial magnetic
stimulation (TMS) as a potential treatment for FND.
One recent controlled trial [94] randomized patients
with paralysis of at least one hand to either active
(subthreshold TMS) or placebo treatment (stimu-
lation of the underlying scalp) before switching to
the other treatment (active/placebo) 2months later.
Significantly, larger median increase in muscular
strength after active compared to sham TMS (24%
versus 6%; P<0.04) was observed. The mechanism
by which TMS could work is, however, still unclear
as placebo effect, suggestion, and neuromodulation
[95] are all possibilities; further studies are still
needed.CONCLUSION
Functional movement disorders are frequent and
diagnosed by clinical positives signs. Psychological
factors alone are not sufficient to explain the etiol-
ogy of FMD, but are important risk factors and/or
maintaining factors. Approach should be multidis-
ciplinary. In the future, the development of special-
ized centres, with both in-patient and out-patient
treatment plans, should be a priority for these
complex patients.
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